Almac Clinical Technologies, part of the Almac Group, has entered a strategic partnership with inVentiv Health that aims to provide clients and sites with streamlined access to best-in-class clinical trial Interactive Response Technology (IRT) solutions.
 
Through the partnership, Almac Clinical Technologies will now provide IRT solutions to inVentiv clients, including its IXRS technology that provides sponsors with visibility and control to help make data-driven decisions. inVentiv’s IRT specialists will also join Almac’s 500+ person consultancy team. This team and technology transition will allow the companies to seamlessly service current inVentiv Health IRT clients.
 
Gregory Skalicky, chief commercial officer, inVentiv Health Clinical Division said, “We’re committed to accelerating clinical trials and see tremendous value in applying leading technology solutions to streamline the process. This partnership will enable inVentiv Health to enhance its clinical services continuum by offering clients access to Almac’s comprehensive, best-in-class IRT services to unlock further efficiencies in trial study configuration and deployment.”
 
Valarie Higgins, president and managing director, Almac Clinical Technologies commented: “This partnership reaffirms Almac’s position as the global leader in clinical technology solutions, like IRT. We’re thrilled to partner with inVentiv Health as their organisational mission aligns seamlessly with the ethos and priorities of the Almac Group. We look forward to our exciting new venture together and the opportunity to offer clients an expanded array of choices to help support the critical work they do every day.”